Site icon Dailybn

Plantar Fasciitis Treatment Market Analysis by Application, Revenue, Players and Vendors to 2027

Transparency Market Research (TMR) has published a new report on the plantar fasciitis treatment market for the forecast period of 2019–2027. According to the report, the global plantar fasciitis treatment market was valued at ~ US$ 695 Mn in 2018, and is projected to expand at a CAGR of 4.3% from 2019 to 2027. Rise in the patient population and surge in the adoption of technologically-advanced products are the major factors anticipated to drive the global plantar fasciitis treatment market from 2019 to 2027.

Identify the Key Factors that will drive your Company’s Growth, Request a Brochure of Plantar Fasciitis Treatment Market Report here

Increase in Burden of Patient Population to Drive Plantar Fasciitis Treatment Market

Orthotics Treatment Type to Gain Market Share and offer Lucrative Opportunities

Asia Pacific Plantar Fasciitis Treatment Market to Grow at a Rapid Pace

Dr. Scholl’s, Superfeet Worldwide, Inc., Hanger, Inc., and Pfizer to Lead Market

The report contains the profiles of leading players operating in the global plantar fasciitis treatment market. These include Hanger, Inc., Bayer Group (Dr. Scholl’s), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc.

The global plantar fasciitis treatment market has been segmented as follows:

Exit mobile version